Heimdall Insights

Global Pregabalin Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: July 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Pregabalin Market was valued at $1.9 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 4.5% CAGR, to an estimated market size of $2.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global pregabalin market encompasses the production and distribution of pregabalin, a gabapentinoid medication acting as an anticonvulsant and anxiolytic. It is primarily indicated for the treatment of neuropathic pain, fibromyalgia, epilepsy (as adjunctive therapy), and generalized anxiety disorder (GAD). The scope includes branded pharmaceuticals, generic formulations, and various dosage forms such as immediate-release capsules, oral solutions, and extended-release tablets.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Pregabalin Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Neuropathic Pain
  • Anxiety Disorders
  • Epilepsy